<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35874696</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis.</ArticleTitle><Pagination><StartPage>941009</StartPage><MedlinePgn>941009</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">941009</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.941009</ELocationID><Abstract><AbstractText>Multisystem inflammatory syndrome in children (MIS-C) is a febrile pediatric inflammatory disease that may develop weeks after initial SARS-CoV-2 infection or exposure. MIS-C involves systemic hyperinflammation and multiorgan involvement, including severe cardiovascular, gastrointestinal (GI) and neurological symptoms. Some clinical attributes of MIS-C-such as persistent fever, rashes, conjunctivitis and oral mucosa changes (red fissured lips and strawberry tongue)-overlap with features of Kawasaki disease (KD). In addition, MIS-C shares striking clinical similarities with toxic shock syndrome (TSS), which is triggered by bacterial superantigens (SAgs). The remarkable similarities between MIS-C and TSS prompted a search for SAg-like structures in the SARS-CoV-2 virus and the discovery of a unique SAg-like motif highly similar to a Staphylococcal enterotoxin B (SEB) fragment in the SARS-CoV-2 spike 1 (S1) glycoprotein. Computational studies suggest that the SAg-like motif has a high affinity for binding T-cell receptors (TCRs) and MHC Class II proteins. Immunosequencing of peripheral blood samples from MIS-C patients revealed a profound expansion of TCR &#x3b2; variable gene 11-2 (TRBV11-2), which correlates with MIS-C severity and serum cytokine levels, consistent with a SAg-triggered immune response. Computational sequence analysis of SARS-CoV-2 spike further identified conserved neurotoxin-like motifs which may alter neuronal cell function and contribute to neurological symptoms in COVID-19 and MIS-C patients. Additionally, autoantibodies are detected during MIS-C, which may indicate development of post-SARS-CoV-2 autoreactive and autoimmune responses. Finally, prolonged persistence of SARS-CoV-2 RNA in the gut, increased gut permeability and elevated levels of circulating S1 have been observed in children with MIS-C. Accordingly, we hypothesize that continuous and prolonged exposure to the viral SAg-like and neurotoxin-like motifs in SARS-CoV-2 spike may promote autoimmunity leading to the development of post-acute COVID-19 syndromes, including MIS-C and long COVID, as well as the neurological complications resulting from SARS-CoV-2 infection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Noval Rivas, Porritt, Cheng, Bahar and Arditi.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Noval Rivas</LastName><ForeName>Magali</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Infectious Diseases and Immunology, Guerin Children's at Cedars-Sinai Medical Center, Los Angeles, CA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious and Immunologic Diseases Research Center (IIDRC) and Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porritt</LastName><ForeName>Rebecca A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Infectious Diseases and Immunology, Guerin Children's at Cedars-Sinai Medical Center, Los Angeles, CA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious and Immunologic Diseases Research Center (IIDRC) and Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Mary Hongying</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahar</LastName><ForeName>Ivet</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arditi</LastName><ForeName>Moshe</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Infectious Diseases and Immunology, Guerin Children's at Cedars-Sinai Medical Center, Los Angeles, CA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious and Immunologic Diseases Research Center (IIDRC) and Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P41 GM103712</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI072726</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM139297</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL139766</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009498">Neurotoxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018089">Superantigens</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000705967">pediatric multisystem inflammatory disease, COVID-19 related</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003240" MajorTopicYN="Y">Connective Tissue Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009498" MajorTopicYN="N">Neurotoxins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018089" MajorTopicYN="N">Superantigens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018746" MajorTopicYN="N">Systemic Inflammatory Response Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MIS-C multisystem inflammatory syndrome in children</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">neurotoxin-like segment</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of COVID-19 (PASC)</Keyword><Keyword MajorTopicYN="N">superantigen</Keyword><Keyword MajorTopicYN="N">superantigen-like motif</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>25</Day><Hour>3</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35874696</ArticleId><ArticleId IdType="pmc">PMC9300823</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.941009</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Grasselli G, Tonetti T, Protti A, Langer T, Girardis M, Bellani G, et al. . Pathophysiology of Covid-19-Associated Acute Respiratory Distress Syndrome: A Multicentre Prospective Observational Study. Lancet Respir Med (2020) 8(12):1201&#x2013;8. doi:&#xa0;10.1016/s2213-2600(20)30370-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(20)30370-2</ArticleId><ArticleId IdType="pmc">PMC7834127</ArticleId><ArticleId IdType="pubmed">32861276</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (Covid-19): A Review. JAMA (2020) 324(8):782&#x2013;93. doi:&#xa0;10.1001/jama.2020.12839</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. . Clinical Course and Risk Factors for Mortality of Adult Inpatients With Covid-19 in Wuhan, China: A Retrospective Cohort Study. Lancet (2020) 395(10229):1054&#x2013;62. doi:&#xa0;10.1016/s0140-6736(20)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao YD, Ding M, Dong X, Zhang JJ, Kursat Azkur A, Azkur D, et al. . Risk Factors for Severe and Critically Ill Covid-19 Patients: A Review. Allergy (2021) 76(2):428&#x2013;55. doi:&#xa0;10.1111/all.14657</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14657</ArticleId><ArticleId IdType="pubmed">33185910</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth A, Reed AB, Ponzo S, Yassaee A, Aral M, Plans D, et al. . Population Risk Factors for Severe Disease and Mortality in Covid-19: A Global Systematic Review and Meta-Analysis. PLoS One (2021) 16(3):e0247461. doi:&#xa0;10.1371/journal.pone.0247461</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0247461</ArticleId><ArticleId IdType="pmc">PMC7932512</ArticleId><ArticleId IdType="pubmed">33661992</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou J, Thomas PG, Randolph AG. Immunology of Sars-Cov-2 Infection in Children. Nat Immunol (2022) 23(2):177&#x2013;85. doi:&#xa0;10.1038/s41590-021-01123-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01123-9</ArticleId><ArticleId IdType="pmc">PMC8981222</ArticleId><ArticleId IdType="pubmed">35105983</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowell AC, Butler MS, Jinks E, Tut G, Lancaster T, Sylla P, et al. . Children Develop Robust and Sustained Cross-Reactive Spike-Specific Immune Responses to Sars-Cov-2 Infection. Nat Immunol (2022) 23(1):40&#x2013;9. doi:&#xa0;10.1038/s41590-021-01089-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01089-8</ArticleId><ArticleId IdType="pmc">PMC8709786</ArticleId><ArticleId IdType="pubmed">34937928</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Sars-Cov-2 Infections in Children: Understanding Diverse Outcomes. Immunity (2022) 55(2):201&#x2013;9. doi:&#xa0;10.1016/j.immuni.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8769938</ArticleId><ArticleId IdType="pubmed">35093190</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. . An Outbreak of Severe Kawasaki-Like Disease at the Italian Epicentre of the Sars-Cov-2 Epidemic: An Observational Cohort Study. Lancet (2020) 395(10239):1771&#x2013;8. doi:&#xa0;10.1016/s0140-6736(20)31103-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)31103-x</ArticleId><ArticleId IdType="pmc">PMC7220177</ArticleId><ArticleId IdType="pubmed">32410760</ArticleId></ArticleIdList></Reference><Reference><Citation>Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory Shock in Children During Covid-19 Pandemic. Lancet (2020) 395(10237):1607&#x2013;8. doi:&#xa0;10.1016/s0140-6736(20)31094-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)31094-1</ArticleId><ArticleId IdType="pmc">PMC7204765</ArticleId><ArticleId IdType="pubmed">32386565</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. . Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Sars-Cov-2. Jama (2020) 324(3):259&#x2013;69. doi:&#xa0;10.1001/jama.2020.10369</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.10369</ArticleId><ArticleId IdType="pmc">PMC7281356</ArticleId><ArticleId IdType="pubmed">32511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. . Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. New Engl J Med (2020) 383(4):334&#x2013;46 . doi:&#xa0;10.1056/nejmoa2021680</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2021680</ArticleId><ArticleId IdType="pmc">PMC7346765</ArticleId><ArticleId IdType="pubmed">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J, et al. . Multisystem Inflammatory Syndrome in Children in New York State. New Engl J Med (2020) 383(4):347&#x2013;58. doi:&#xa0;10.1056/nejmoa2021756</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2021756</ArticleId><ArticleId IdType="pmc">PMC7346766</ArticleId><ArticleId IdType="pubmed">32598830</ArticleId></ArticleIdList></Reference><Reference><Citation>Belhadjer Z, M&#xe9;ot M, Bajolle F, Khraiche D, Legendre A, Abakka S, et al. . Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global Sars-Cov-2 Pandemic. Circulation (2020) 142(5):429&#x2013;36. doi:&#xa0;10.1161/circulationaha.120.048360</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circulationaha.120.048360</ArticleId><ArticleId IdType="pubmed">32418446</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulman ST. Pediatric Coronavirus Disease-2019-Associated Multisystem Inflammatory Syndrome. J Pediatr Infect Dis Soc (2020) 9(3):285&#x2013;6. doi:&#xa0;10.1093/jpids/piaa062</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piaa062</ArticleId><ArticleId IdType="pmc">PMC7313948</ArticleId><ArticleId IdType="pubmed">32441751</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowley AH. Understanding Sars-Cov-2-Related Multisystem Inflammatory Syndrome in Children. Nat Rev Immunol (2020), 20(8):453&#x2013;4 . doi:&#xa0;10.1038/s41577-020-0367-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0367-5</ArticleId><ArticleId IdType="pmc">PMC7296515</ArticleId><ArticleId IdType="pubmed">32546853</ArticleId></ArticleIdList></Reference><Reference><Citation>Vella LA, Rowley AH. Current Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome in Children. Curr Pediatr Rep (2021), 1&#x2013;10 Epub 20211019. doi:&#xa0;10.1007/s40124-021-00257-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40124-021-00257-6</ArticleId><ArticleId IdType="pmc">PMC8524214</ArticleId><ArticleId IdType="pubmed">34692237</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris SB, Schwartz NG, Patel P, Abbo L, Beauchamps L, Balan S, et al. . Case Series of Multisystem Inflammatory Syndrome in Adults Associated With Sars-Cov-2 Infection - United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep (2020) 69(40):1450&#x2013;6. doi:&#xa0;10.15585/mmwr.mm6940e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6940e1</ArticleId><ArticleId IdType="pmc">PMC7561225</ArticleId><ArticleId IdType="pubmed">33031361</ArticleId></ArticleIdList></Reference><Reference><Citation>Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, et al. . Kawasaki-Like Multisystem Inflammatory Syndrome in Children During the Covid-19 Pandemic in Paris, France: Prospective Observational Study. Bmj (2020) 369:m2094. doi:&#xa0;10.1136/bmj.m2094</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2094</ArticleId><ArticleId IdType="pmc">PMC7500538</ArticleId><ArticleId IdType="pubmed">32493739</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung EW, Zachariah P, Gorelik M, Boneparth A, Kernie SG, Orange JS, et al. . Multisystem Inflammatory Syndrome Related to Covid-19 in Previously Healthy Children and Adolescents in New York City. Jama (2020) 324(3):294&#x2013;6. doi:&#xa0;10.1001/jama.2020.10374</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.10374</ArticleId><ArticleId IdType="pmc">PMC7281352</ArticleId><ArticleId IdType="pubmed">32511676</ArticleId></ArticleIdList></Reference><Reference><Citation>
CDC . Health Department-Reported Cases of Multisystem Inflammatory Syndrome in Children (Mis-C) in the United States (2022). Available at: https://covidcdcgov/covid-data-tracker/#mis-national-surveillance.</Citation></Reference><Reference><Citation>Belay ED, Abrams J, Oster ME, Giovanni J, Pierce T, Meng L, et al. . Trends in Geographic and Temporal Distribution of Us Children With Multisystem Inflammatory Syndrome During the Covid-19 Pandemic. JAMA Pediatr (2021) 175(8):837&#x2013;45. doi:&#xa0;10.1001/jamapediatrics.2021.0630</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.0630</ArticleId><ArticleId IdType="pmc">PMC8025123</ArticleId><ArticleId IdType="pubmed">33821923</ArticleId></ArticleIdList></Reference><Reference><Citation>McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. . Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation (2017) 135(17):e927&#x2013;e99. doi:&#xa0;10.1161/cir.0000000000000484</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/cir.0000000000000484</ArticleId><ArticleId IdType="pubmed">28356445</ArticleId></ArticleIdList></Reference><Reference><Citation>Soni PR, Noval Rivas M, Arditi M. A Comprehensive Update on Kawasaki Disease Vasculitis and Myocarditis. Curr Rheumatol Rep (2020) 22(2):6. doi:&#xa0;10.1007/s11926-020-0882-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-020-0882-1</ArticleId><ArticleId IdType="pubmed">32020498</ArticleId></ArticleIdList></Reference><Reference><Citation>Newburger JW, Takahashi M, Burns JC. Kawasaki Disease. J Am Coll Cardiol (2016) 67(14):1738&#x2013;49. doi: 10.1016/j.jacc.2015.12.073</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.12.073</ArticleId><ArticleId IdType="pubmed">27056781</ArticleId></ArticleIdList></Reference><Reference><Citation>Godfred-Cato S, Abrams JY, Balachandran N, Jaggi P, Jones K, Rostad CA, et al. . Distinguishing Multisystem Inflammatory Syndrome in Children From Covid-19, Kawasaki Disease and Toxic Shock Syndrome. Pediatr Infect Dis J (2022) 41(4):315&#x2013;23. doi:&#xa0;10.1097/inf.0000000000003449</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/inf.0000000000003449</ArticleId><ArticleId IdType="pmc">PMC8919949</ArticleId><ArticleId IdType="pubmed">35093995</ArticleId></ArticleIdList></Reference><Reference><Citation>Farooqi KM, Chan A, Weller RJ, Mi J, Jiang P, Abrahams E, et al. . Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children. Pediatrics (2021) 148(2):e2021051155. doi:&#xa0;10.1542/peds.2021-051155</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2021-051155</ArticleId><ArticleId IdType="pubmed">34266903</ArticleId></ArticleIdList></Reference><Reference><Citation>Jhaveri S, Ahluwalia N, Kaushik S, Trachtman R, Kowalsky S, Aydin S, et al. . Longitudinal Echocardiographic Assessment of Coronary Arteries and Left Ventricular Function Following Multisystem Inflammatory Syndrome in Children. J Pediatr (2021) 228:290&#x2013;3.e1. doi:&#xa0;10.1016/j.jpeds.2020.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2020.08.002</ArticleId><ArticleId IdType="pmc">PMC7403848</ArticleId><ArticleId IdType="pubmed">32768467</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook A, Janse S, Watson JR, Erdem G. Manifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010-2017(1). Emerg Infect Dis (2020) 26(6):1077&#x2013;83. doi:&#xa0;10.3201/eid2606.190783</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2606.190783</ArticleId><ArticleId IdType="pmc">PMC7258457</ArticleId><ArticleId IdType="pubmed">32442091</ArticleId></ArticleIdList></Reference><Reference><Citation>Low DE. Toxic Shock Syndrome: Major Advances in Pathogenesis, But Not Treatment. Crit Care Clin (2013) 29(3):651&#x2013;75. doi:&#xa0;10.1016/j.ccc.2013.03.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2013.03.012</ArticleId><ArticleId IdType="pubmed">23830657</ArticleId></ArticleIdList></Reference><Reference><Citation>Basalely A, Gurusinghe S, Schneider J, Shah SS, Siegel LB, Pollack G, et al. . Acute Kidney Injury in Pediatric Patients Hospitalized With Acute Covid-19 and Multisystem Inflammatory Syndrome in Children Associated With Covid-19. Kidney Int (2021) 100(1):138&#x2013;45. doi:&#xa0;10.1016/j.kint.2021.02.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2021.02.026</ArticleId><ArticleId IdType="pmc">PMC7927648</ArticleId><ArticleId IdType="pubmed">33675848</ArticleId></ArticleIdList></Reference><Reference><Citation>Krakauer T. Staphylococcal Superantigens: Pyrogenic Toxins Induce Toxic Shock. Toxins (2019) 11(3):178. doi: 10.3390/toxins11030178</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxins11030178</ArticleId><ArticleId IdType="pmc">PMC6468478</ArticleId><ArticleId IdType="pubmed">30909619</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatila T, Geha RS. Superantigens. Curr Opin Immunol (1992) 4(1):74&#x2013;8. doi:&#xa0;10.1016/0952-7915(92)90129-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0952-7915(92)90129-3</ArticleId><ArticleId IdType="pubmed">1596371</ArticleId></ArticleIdList></Reference><Reference><Citation>Chesney PJ, Bergdoll MS, Davis JP, Vergeront JM. The Disease Spectrum, Epidemiology, and Etiology of Toxic-Shock Syndrome. Annu Rev Microbiol (1984) 38:315&#x2013;38. doi:&#xa0;10.1146/annurev.mi.38.100184.001531</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.mi.38.100184.001531</ArticleId><ArticleId IdType="pubmed">6388495</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd JK. Toxic Shock Syndrome. Clin Microbiol Rev (1988) 1(4):432&#x2013;46. doi:&#xa0;10.1128/cmr.1.4.432</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/cmr.1.4.432</ArticleId><ArticleId IdType="pmc">PMC358064</ArticleId><ArticleId IdType="pubmed">3069202</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosene KA, Copass MK, Kastner LS, Nolan CM, Eschenbach DA. Persistent Neuropsychological Sequelae of Toxic Shock Syndrome. Ann Intern Med (1982) 96(6 Pt 2):865&#x2013;70. doi:&#xa0;10.7326/0003-4819-96-6-865</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-96-6-865</ArticleId><ArticleId IdType="pubmed">7091958</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutkowski N, Palkama T, Ciurli C, Sekaly RP, Thorley-Lawson DA, Huber BT. An Epstein-Barr Virus-Associated Superantigen. J Exp Med (1996) 184(3):971&#x2013;80. doi:&#xa0;10.1084/jem.184.3.971</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.184.3.971</ArticleId><ArticleId IdType="pmc">PMC2192769</ArticleId><ArticleId IdType="pubmed">9064357</ArticleId></ArticleIdList></Reference><Reference><Citation>Raftery MJ, Behrens CK, M&#xfc;ller A, Krammer PH, Walczak H, Sch&#xf6;nrich G. Herpes Simplex Virus Type 1 Infection of Activated Cytotoxic T Cells: Induction of Fratricide as a Mechanism of Viral Immune Evasion. J Exp Med (1999) 190(8):1103&#x2013;14. doi:&#xa0;10.1084/jem.190.8.1103</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.190.8.1103</ArticleId><ArticleId IdType="pmc">PMC2195666</ArticleId><ArticleId IdType="pubmed">10523608</ArticleId></ArticleIdList></Reference><Reference><Citation>Leroy EM, Becquart P, Wauquier N, Baize S. Evidence for Ebola Virus Superantigen Activity. J Virol (2011) 85(8):4041&#x2013;2. doi:&#xa0;10.1128/jvi.00181-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00181-11</ArticleId><ArticleId IdType="pmc">PMC3126126</ArticleId><ArticleId IdType="pubmed">21307193</ArticleId></ArticleIdList></Reference><Reference><Citation>Conrad B, Weissmahr RN, B&#xf6;ni J, Arcari R, Sch&#xfc;pbach J, Mach B. A Human Endogenous Retroviral Superantigen as Candidate Autoimmune Gene in Type I Diabetes. Cell (1997) 90(2):303&#x2013;13. doi:&#xa0;10.1016/s0092-8674(00)80338-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(00)80338-4</ArticleId><ArticleId IdType="pubmed">9244304</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrescu D, Ursea B, Pope M, Asch AS, Posnett DN. Enhanced Hiv-1 Replication in V Beta 12 T Cells Due to Human Cytomegalovirus in Monocytes: Evidence for a Putative Herpesvirus Superantigen. Cell (1995) 82(5):753&#x2013;63. doi:&#xa0;10.1016/0092-8674(95)90472-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(95)90472-7</ArticleId><ArticleId IdType="pubmed">7671303</ArticleId></ArticleIdList></Reference><Reference><Citation>Karray S, Zouali M. Identification of the B Cell Superantigen-Binding Site of Hiv-1&#x2009;Gp120. Proc Natl Acad Sci (1997) 94(4):1356&#x2013;60. doi:&#xa0;10.1073/pnas.94.4.1356</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.94.4.1356</ArticleId><ArticleId IdType="pmc">PMC19795</ArticleId><ArticleId IdType="pubmed">9037057</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafon M, Lafage M, Martinez-Arends A, Ramirez R, Vuillier F, Charron D, et al. . Evidence for a Viral Superantigen in Humans. Nature (1992) 358(6386):507&#x2013;10. doi:&#xa0;10.1038/358507a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/358507a0</ArticleId><ArticleId IdType="pubmed">1386410</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng MH, Zhang S, Porritt RA, Noval Rivas M, Paschold L, Willscher E, et al. . Superantigenic Character of an Insert Unique to Sars-Cov-2 Spike Supported by Skewed Tcr Repertoire in Patients With Hyperinflammation. Proc Natl Acad Sci U.S.A. (2020) 117(41):25254&#x2013;62. doi:&#xa0;10.1073/pnas.2010722117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2010722117</ArticleId><ArticleId IdType="pmc">PMC7568239</ArticleId><ArticleId IdType="pubmed">32989130</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls AC, Park Y-J, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, Function, and Antigenicity of the Sars-Cov-2 Spike Glycoprotein. Cell (2020) 181(2):281&#x2013;92.e6. doi:&#xa0;10.1016/j.cell.2020.02.058</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.058</ArticleId><ArticleId IdType="pmc">PMC7102599</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of Sars-Cov-2 Entry Into Cells. Nat Rev Mol Cell Biol (2022) 23(1):3&#x2013;20. doi:&#xa0;10.1038/s41580-021-00418-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BA, Xie X, Bailey AL, Kalveram B, Lokugamage KG, Muruato A, et al. . Loss of Furin Cleavage Site Attenuates Sars-Cov-2 Pathogenesis. Nature (2021) 591(7849):293&#x2013;9. doi:&#xa0;10.1038/s41586-021-03237-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03237-4</ArticleId><ArticleId IdType="pmc">PMC8175039</ArticleId><ArticleId IdType="pubmed">33494095</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau S-Y, Wang P, Mok BW-Y, Zhang AJ, Chu H, Lee AC-Y, et al. . Attenuated Sars-Cov-2 Variants With Deletions at the S1/S2 Junction. Emerging Microbes Infections (2020) 9(1):837&#x2013;42. doi:&#xa0;10.1080/22221751.2020.1756700</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1756700</ArticleId><ArticleId IdType="pmc">PMC7241555</ArticleId><ArticleId IdType="pubmed">32301390</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogata AF, Maley AM, Wu C, Gilboa T, Norman M, Lazarovits R, et al. . Ultra-Sensitive Serial Profiling of Sars-Cov-2 Antigens and Antibodies in Plasma to Understand Disease Progression in Covid-19 Patients With Severe Disease. Clin Chem (2020) 66(12):1562&#x2013;72. doi:&#xa0;10.1093/clinchem/hvaa213</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/hvaa213</ArticleId><ArticleId IdType="pmc">PMC7499543</ArticleId><ArticleId IdType="pubmed">32897389</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker LM, Gilboa T, Ogata AF, Senussi Y, Lazarovits R, Boribong BP, et al. . Multisystem Inflammatory Syndrome in Children Is Driven by Zonulin-Dependent Loss of Gut Mucosal Barrier. J Clin Invest (2021) 131(14):e149633. doi:&#xa0;10.1172/jci149633</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci149633</ArticleId><ArticleId IdType="pmc">PMC8279585</ArticleId><ArticleId IdType="pubmed">34032635</ArticleId></ArticleIdList></Reference><Reference><Citation>Noval Rivas M, Porritt RA, Cheng MH, Bahar I, Arditi M. Covid-19-Associated Multisystem Inflammatory Syndrome in Children (Mis-C): A Novel Disease That Mimics Toxic Shock Syndrome-The Superantigen Hypothesis. J Allergy Clin Immunol (2021) 147(1):57&#x2013;9. doi:&#xa0;10.1016/j.jaci.2020.10.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.10.008</ArticleId><ArticleId IdType="pmc">PMC7564502</ArticleId><ArticleId IdType="pubmed">33075409</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham PL, 3rd, Lin SX, Larson EL. A U.S. Population-Based Survey of Staphylococcus Aureus Colonization. Ann Intern Med (2006) 144(5):318&#x2013;25. doi:&#xa0;10.7326/0003-4819-144-5-200603070-00006</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-144-5-200603070-00006</ArticleId><ArticleId IdType="pubmed">16520472</ArticleId></ArticleIdList></Reference><Reference><Citation>
Ross A, Shoff HW. Toxic Shock Syndrome. In: Statpearls. Treasure Island (FL)
StatPearls Publishing LLC;  (2022). Available from: https://www.ncbi.nlm.nih.gov/books/NBK459345/?report=classic
</Citation><ArticleIdList><ArticleId IdType="pubmed">29083727</ArticleId></ArticleIdList></Reference><Reference><Citation>LeClaire RD, Bavari S. Human Antibodies to Bacterial Superantigens and Their Ability to Inhibit T-Cell Activation and Lethality. Antimicrob Agents Chemother (2001) 45(2):460&#x2013;3. doi:&#xa0;10.1128/aac.45.2.460-463.2001</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/aac.45.2.460-463.2001</ArticleId><ArticleId IdType="pmc">PMC90313</ArticleId><ArticleId IdType="pubmed">11158741</ArticleId></ArticleIdList></Reference><Reference><Citation>McGann VG, Rollins JB, Mason DW. Evaluation of Resistance to Staphylococcal Enterotoxin B: Naturally Acquired Antibodies of Man and Monkey. J Infect Dis (1971) 124(2):206&#x2013;13. doi:&#xa0;10.1093/infdis/124.2.206</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/124.2.206</ArticleId><ArticleId IdType="pubmed">5001454</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell DE, Kemp AS. Production of Antibodies to Staphylococcal Superantigens in Atopic Dermatitis. Arch Dis Child (1998) 79(5):400&#x2013;4. doi:&#xa0;10.1136/adc.79.5.400</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.79.5.400</ArticleId><ArticleId IdType="pmc">PMC1717757</ArticleId><ArticleId IdType="pubmed">10193251</ArticleId></ArticleIdList></Reference><Reference><Citation>Varshney AK, Wang X, Cook E, Dutta K, Scharff MD, Goger MJ, et al. . Generation, Characterization, and Epitope Mapping of Neutralizing and Protective Monoclonal Antibodies Against Staphylococcal Enterotoxin B-Induced Lethal Shock *&lt;Sup&gt;&lt;/Sup&gt;. J Biol Chem (2011) 286(11):9737&#x2013;47. doi:&#xa0;10.1074/jbc.M110.212407</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.212407</ArticleId><ArticleId IdType="pmc">PMC3059042</ArticleId><ArticleId IdType="pubmed">21233204</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng MH, Porritt RA, Rivas MN, Krieger JM, Ozdemir AB, Garcia G, Jr., et al. . A Monoclonal Antibody Against Staphylococcal Enterotoxin B Superantigen Inhibits Sars-Cov-2 Entry In Vitro . Structure (2021) 29(9):951&#x2013;62.e3. doi:&#xa0;10.1016/j.str.2021.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2021.04.005</ArticleId><ArticleId IdType="pmc">PMC8082696</ArticleId><ArticleId IdType="pubmed">33930306</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer TC, Michalik S, Holtfreter S, Weiss S, Friedrich N, V&#xf6;lzke H, et al. . A Comprehensive View on the Human Antibody Repertoire Against Staphylococcus Aureus Antigens in the General Population. Front Immunol (2021) 12:651619. doi:&#xa0;10.3389/fimmu.2021.651619</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.651619</ArticleId><ArticleId IdType="pmc">PMC7987813</ArticleId><ArticleId IdType="pubmed">33777051</ArticleId></ArticleIdList></Reference><Reference><Citation>Vergeront JM, Stolz SJ, Crass BA, Nelson DB, Davis JP, Bergdoll MS. Prevalence of Serum Antibody to Staphylococcal Enterotoxin F Among Wisconsin Residents: Implications for Toxic-Shock Syndrome. J Infect Dis (1983) 148(4):692&#x2013;8. doi:&#xa0;10.1093/infdis/148.4.692</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/148.4.692</ArticleId><ArticleId IdType="pubmed">6631061</ArticleId></ArticleIdList></Reference><Reference><Citation>Takei S, Arora YK, Walker SM. Intravenous Immunoglobulin Contains Specific Antibodies Inhibitory to Activation of T Cells by Staphylococcal Toxin Superantigens [See Comment]. J Clin Invest (1993) 91(2):602&#x2013;7. doi:&#xa0;10.1172/JCI116240</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI116240</ArticleId><ArticleId IdType="pmc">PMC287991</ArticleId><ArticleId IdType="pubmed">8432865</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishi JI, Kanekura S, Takei S, Kitajima I, Nakajima T, Wahid MR, et al. . B Cell Epitope Mapping of the Bacterial Superantigen Staphylococcal Enterotoxin B: The Dominant Epitope Region Recognized by Intravenous Igg. J Immunol (1997) 158(1):247&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">8977196</ArticleId></ArticleIdList></Reference><Reference><Citation>Deacy AM, Gan SK-E, Derrick JP. Superantigen Recognition and Interactions: Functions, Mechanisms and Applications. Front Immunol (2021) 12:731845. doi:&#xa0;10.3389/fimmu.2021.731845</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.731845</ArticleId><ArticleId IdType="pmc">PMC8488440</ArticleId><ArticleId IdType="pubmed">34616400</ArticleId></ArticleIdList></Reference><Reference><Citation>Hongmin Li, Llera A, Malchiodi EL, Mariuzza RA. The Structural Basis of T Cell Activation by Superantigens. Annu Rev Immunol (1999) 17(1):435&#x2013;66. doi:&#xa0;10.1146/annurev.immunol.17.1.435</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.17.1.435</ArticleId><ArticleId IdType="pubmed">10358765</ArticleId></ArticleIdList></Reference><Reference><Citation>Porritt RA, Paschold L, Rivas MN, Cheng MH, Yonker LM, Chandnani H, et al. . HLA Class I-Associated Expansion of Trbv11-2 T Cells in Multisystem Inflammatory Syndrome in Children. J Clin Invest (2021) 131(10):e146614. doi:&#xa0;10.1172/jci146614</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci146614</ArticleId><ArticleId IdType="pmc">PMC8121516</ArticleId><ArticleId IdType="pubmed">33705359</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreews M, Le Gouge K, Khaldi-Plassart S, Pescarmona R, Mathieu AL, Malcus C, et al. . Polyclonal Expansion of Tcr Vbeta 21.3(+) Cd4(+) and Cd8(+) T Cells Is a Hallmark of Multisystem Inflammatory Syndrome in Children. Sci Immunol (2021) 6(59):eabh1516. doi:&#xa0;10.1126/sciimmunol.abh1516</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abh1516</ArticleId><ArticleId IdType="pmc">PMC8815705</ArticleId><ArticleId IdType="pubmed">34035116</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste L, Roels L, Naesens L, Bosteels V, Vanhee S, Dupont S, et al. . Tim3+ Trbv11-2 T Cells and Ifngamma Signature in Patrolling Monocytes and Cd16+ Nk Cells Delineate Mis-C. J Exp Med (2022) 219(2):e20211381. doi:&#xa0;10.1084/jem.20211381</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20211381</ArticleId><ArticleId IdType="pmc">PMC8685281</ArticleId><ArticleId IdType="pubmed">34914824</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacco K, Castagnoli R, Vakkilainen S, Liu C, Delmonte OM, Oguz C, et al. . Immunopathological Signatures in Multisystem Inflammatory Syndrome in Children and Pediatric Covid-19. Nat Med (2022) 28(5):1050&#x2013;62. doi:&#xa0;10.1038/s41591-022-01724-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01724-3</ArticleId><ArticleId IdType="pmc">PMC9119950</ArticleId><ArticleId IdType="pubmed">35177862</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramaswamy A, Brodsky NN, Sumida TS, Comi M, Asashima H, Hoehn KB, et al. . Immune Dysregulation and Autoreactivity Correlate With Disease Severity in Sars-Cov-2-Associated Multisystem Inflammatory Syndrome in Children. Immunity (2021) 54(5):1083&#x2013;95.e7. doi:&#xa0;10.1016/j.immuni.2021.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.04.003</ArticleId><ArticleId IdType="pmc">PMC8043654</ArticleId><ArticleId IdType="pubmed">33891889</ArticleId></ArticleIdList></Reference><Reference><Citation>Llewelyn M, Sriskandan S, Peakman M, Ambrozak DR, Douek DC, Kwok WW, et al. . Hla Class Ii Polymorphisms Determine Responses to Bacterial Superantigens. J Immunol (2004) 172(3):1719&#x2013;26. doi:&#xa0;10.4049/jimmunol.172.3.1719</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.172.3.1719</ArticleId><ArticleId IdType="pubmed">14734754</ArticleId></ArticleIdList></Reference><Reference><Citation>Llewelyn M. Human Leukocyte Antigen Class Ii Haplotypes That Protect Against or Predispose to Streptococcal Toxic Shock. Clin Infect Dis (2005) 41(Supplement_7):S445&#x2013;S8. doi:&#xa0;10.1086/431986</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/431986</ArticleId><ArticleId IdType="pubmed">16237645</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway SR, Lazarski CA, Field NE, Jensen-Wachspress M, Lang H, Kankate V, et al. . Sars-Cov-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated Sars-Cov-2 Infection. Front Immunol (2022) 12:793197. doi:&#xa0;10.3389/fimmu.2021.793197</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.793197</ArticleId><ArticleId IdType="pmc">PMC8803660</ArticleId><ArticleId IdType="pubmed">35116027</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C, Wong P, Klein J, Castro TBR, Silva J, Sundaram M, et al. . Longitudinal Analyses Reveal Immunological Misfiring in Severe Covid-19. Nature (2020) 584(7821):463&#x2013;9. doi:&#xa0;10.1038/s41586-020-2588-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2588-y</ArticleId><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, Dai Y, Huck JD, Jaycox JR, et al. . Diverse Functional Autoantibodies in Patients With Covid-19. Nature (2021) 595(7866):283&#x2013;8. doi:&#xa0;10.1038/s41586-021-03631-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SE, Feng A, Meng W, Apostolidis SA, Mack E, Artandi M, et al. . New-Onset Igg Autoantibodies in Hospitalized Patients With Covid-19. Nat Commun (2021) 12(1):5417. doi:&#xa0;10.1038/s41467-021-25509-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25509-3</ArticleId><ArticleId IdType="pmc">PMC8440763</ArticleId><ArticleId IdType="pubmed">34521836</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhadelia N, Belkina AC, Olson A, Winters T, Urick P, Lin N, et al. . Distinct Autoimmune Antibody Signatures Between Hospitalized Acute Covid-19 Patients, Sars-Cov-2 Convalescent Individuals, and Unexposed Pre-Pandemic Controls. Medrxiv (2021) 2021.01.21.21249176. doi:&#xa0;10.1101/2021.01.21.21249176</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.21.21249176</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanay A. Chikungunya Virus and Autoimmunity. Curr Opin Rheumatol (2017) 29(4):389&#x2013;93. doi:&#xa0;10.1097/bor.0000000000000396</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/bor.0000000000000396</ArticleId><ArticleId IdType="pubmed">28376065</ArticleId></ArticleIdList></Reference><Reference><Citation>Jog NR, James JA. Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus. Front Immunol (2021) 11:623944. doi:&#xa0;10.3389/fimmu.2020.623944</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.623944</ArticleId><ArticleId IdType="pmc">PMC7886683</ArticleId><ArticleId IdType="pubmed">33613559</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Casals M. Viruses and Lupus: The Viral Hypothesis. LUPUS (2008) 17(3):163&#x2013;5. doi:&#xa0;10.1177/0961203307086268</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203307086268</ArticleId><ArticleId IdType="pubmed">18372354</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, et al. . Longitudinal Analysis Reveals High Prevalence of Epstein-Barr Virus Associated With Multiple Sclerosis. Science (2022) 375(6578):296&#x2013;301. doi:&#xa0;10.1126/science.abj8222</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj8222</ArticleId><ArticleId IdType="pubmed">35025605</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. . Post-Acute Covid-19 Syndrome. Nat Med (2021) 27(4):601&#x2013;15. doi:&#xa0;10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. . Attributes and Predictors of Long Covid. Nat Med (2021) 27(4):626&#x2013;31. doi:&#xa0;10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. . Multiple Early Factors Anticipate Post-Acute Covid-19 Sequelae. Cell (2022) 185(5):881&#x2013;95.e20. doi:&#xa0;10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al. . Short-Term and Long-Term Rates of Postacute Sequelae of Sars-Cov-2 Infection: A Systematic Review. JAMA Network Open (2021) 4(10):e2128568&#x2013;e. doi:&#xa0;10.1001/jamanetworkopen.2021.28568</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Bateman L. Will Covid-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? Front Med (2021) 7:606824. doi:&#xa0;10.3389/fmed.2020.606824</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.606824</ArticleId><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained Post-Acute Infection Syndromes. Nat Med (2022) 28(5):911&#x2013;23. doi:&#xa0;10.1038/s41591-022-01810-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Wucherpfennig KW. Mechanisms for the Induction of Autoimmunity by Infectious Agents. J Clin Invest (2001) 108(8):1097&#x2013;104. doi:&#xa0;10.1172/JCI14235</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI14235</ArticleId><ArticleId IdType="pmc">PMC209539</ArticleId><ArticleId IdType="pubmed">11602615</ArticleId></ArticleIdList></Reference><Reference><Citation>Getts DR, Chastain EM, Terry RL, Miller SD. Virus Infection, Antiviral Immunity, and Autoimmunity. Immunol Rev (2013) 255(1):197&#x2013;209. doi:&#xa0;10.1111/imr.12091</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12091</ArticleId><ArticleId IdType="pmc">PMC3971377</ArticleId><ArticleId IdType="pubmed">23947356</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujinami RS. Viruses and Autoimmune Disease - Two Sides of the Same Coin? Trends Microbiol (2001) 9(8):377&#x2013;81. doi:&#xa0;10.1016/S0966-842X(01)02097-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0966-842X(01)02097-2</ArticleId><ArticleId IdType="pmc">PMC7127302</ArticleId><ArticleId IdType="pubmed">11514220</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M, Restrepo-Jim&#xe9;nez P, Monsalve DM, Pacheco Y, Acosta-Ampudia Y, Ram&#xed;rez-Santana C, et al. . Molecular Mimicry and Autoimmunity. J Autoimmun (2018) 95:100&#x2013;23. doi:&#xa0;10.1016/j.jaut.2018.10.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.10.012</ArticleId><ArticleId IdType="pubmed">30509385</ArticleId></ArticleIdList></Reference><Reference><Citation>Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM. Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms. Viruses (2019) 11(8):762. doi:&#xa0;10.3390/v11080762</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11080762</ArticleId><ArticleId IdType="pmc">PMC6723519</ArticleId><ArticleId IdType="pubmed">31430946</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nz C, L&#xfc;nemann JD, Getts MT, Miller SD. Antiviral Immune Responses: Triggers of or Triggered by Autoimmunity? Nat Rev Immunol (2009) 9(4):246&#x2013;58. doi:&#xa0;10.1038/nri2527</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2527</ArticleId><ArticleId IdType="pmc">PMC2854652</ArticleId><ArticleId IdType="pubmed">19319143</ArticleId></ArticleIdList></Reference><Reference><Citation>Krakauer T, Pradhan K, Stiles BG. Staphylococcal Superantigens Spark Host-Mediated Danger Signals. Front Immunol (2016) 7:23. doi:&#xa0;10.3389/fimmu.2016.00023</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00023</ArticleId><ArticleId IdType="pmc">PMC4735405</ArticleId><ArticleId IdType="pubmed">26870039</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuri-Cervantes L, Pampena MB, Meng W, Rosenfeld AM, Ittner CAG, Weisman AR, et al. . Comprehensive Mapping of Immune Perturbations Associated With Severe Covid-19. Sci Immunol (2020) 5(49) :eabd7114. doi:&#xa0;10.1126/sciimmunol.abd7114</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abd7114</ArticleId><ArticleId IdType="pmc">PMC7402634</ArticleId><ArticleId IdType="pubmed">32669287</ArticleId></ArticleIdList></Reference><Reference><Citation>Vella LA, Giles JR, Baxter AE, Oldridge DA, Diorio C, Kuri-Cervantes L, et al. . Deep Immune Profiling of Mis-C Demonstrates Marked But Transient Immune Activation Compared to Adult and Pediatric Covid-19. Sci Immunol (2021) 6(57):eabf7570. doi:&#xa0;10.1126/sciimmunol.abf7570</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abf7570</ArticleId><ArticleId IdType="pmc">PMC8128303</ArticleId><ArticleId IdType="pubmed">33653907</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. . Immunological Dysfunction Persists for 8 Months Following Initial Mild-To-Moderate Sars-Cov-2 Infection. Nat Immunol (2022) 23(2):210&#x2013;6. doi:&#xa0;10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, Zlitni S, Brooks EF, Vance SE, Dahlen A, Hedlin H, et al. . Gastrointestinal Symptoms and Fecal Shedding of Sars-Cov-2 Rna Suggest Prolonged Gastrointestinal Infection. Med. (2022) 3(6):371&#x2013;87.e9. doi. doi:&#xa0;10.1016/j.medj.2022.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, et al. . Evolution of Antibody Immunity to Sars-Cov-2. Nature (2021) 591(7851):639&#x2013;44. doi:&#xa0;10.1038/s41586-021-03207-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung CCL, Goh D, Lim X, Tien TZ, Lim JCT, Lee JN, et al. . Residual Sars-Cov-2 Viral Antigens Detected in Gi and Hepatic Tissues From Five Recovered Patients With Covid-19. Gut (2022) 71(1):226&#x2013;9. doi:&#xa0;10.1136/gutjnl-2021-324280</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324280</ArticleId><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Giron LB, Dweep H, Yin X, Wang H, Damra M, Goldman AR, et al. . Plasma Markers of Disrupted Gut Permeability in Severe Covid-19 Patients. Front Immunol (2021) 12:686240. doi:&#xa0;10.3389/fimmu.2021.686240</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686240</ArticleId><ArticleId IdType="pmc">PMC8219958</ArticleId><ArticleId IdType="pubmed">34177935</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A, Koch R, Jukic A, Pfister A, Meyer M, R&#xf6;ssler A, et al. . Post-Acute Covid-19 Is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases. Gastroenterology (2022) S0016-5085(22):00450-4. doi:&#xa0;10.1053/j.gastro.2022.04.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasigade JP, Thomas D, Perpoint T, Peyramond D, Chidiac C, Etienne J, et al. . T-Cell Response to Superantigen Restimulation During Menstrual Toxic Shock Syndrome. FEMS Immunol Med Microbiol (2011) 62(3):368&#x2013;71. doi:&#xa0;10.1111/j.1574-695X.2011.00808.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-695X.2011.00808.x</ArticleId><ArticleId IdType="pubmed">21492259</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis JP, Chesney PJ, Wand PJ, LaVenture M. Toxic-Shock Syndrome: Epidemiologic Features, Recurrence, Risk Factors, and Prevention. N Engl J Med (1980) 303(25):1429&#x2013;35. doi:&#xa0;10.1056/nejm198012183032501</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejm198012183032501</ArticleId><ArticleId IdType="pubmed">7432401</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu SX, McCormick JK. Staphylococcal Superantigens in Colonization and Disease. Front Cell Infect Microbiol (2012) 2:52. doi:&#xa0;10.3389/fcimb.2012.00052</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2012.00052</ArticleId><ArticleId IdType="pmc">PMC3417409</ArticleId><ArticleId IdType="pubmed">22919643</ArticleId></ArticleIdList></Reference><Reference><Citation>Kain KC, Schulzer M, Chow AW. Clinical Spectrum of Nonmenstrual Toxic Shock Syndrome (Tss): Comparison With Menstrual Tss by Multivariate Discriminant Analyses. Clin Infect Dis (1993) 16(1):100&#x2013;6. doi:&#xa0;10.1093/clinids/16.1.100</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/16.1.100</ArticleId><ArticleId IdType="pubmed">8448283</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews MM, Parent EM, Barry M, Parsonnet J. Recurrent Nonmenstrual Toxic Shock Syndrome: Clinical Manifestations, Diagnosis, and Treatment. Clin Infect Dis (2001) 32(10):1470&#x2013;9. doi:&#xa0;10.1086/320170</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/320170</ArticleId><ArticleId IdType="pubmed">11317249</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald HR, Lees RK, Baschieri S, Herrmann T, Lussow AR. Peripheral T-Cell Reactivity to Bacterial Superantigens in Vivo: The Response/Anergy Paradox. Immunol Rev (1993) 133:105&#x2013;17. doi:&#xa0;10.1111/j.1600-065x.1993.tb01512.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065x.1993.tb01512.x</ArticleId><ArticleId IdType="pubmed">8225363</ArticleId></ArticleIdList></Reference><Reference><Citation>Florquin S, Amraoui Z, Goldman M. T Cells Made Deficient in Interleukin-2 Production by Exposure to Staphylococcal Enterotoxin B in Vivo Are Primed for Interferon-Gamma and Interleukin-10 Secretion. Eur J Immunol (1995) 25(5):1148&#x2013;53. doi:&#xa0;10.1002/eji.1830250503</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.1830250503</ArticleId><ArticleId IdType="pubmed">7774618</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaus H, Miethke T, Wagner H, Heeg K. Superantigen-Induced Anergy of V Beta 8+ Cd4+ T Cells Induces Functional But Non-Proliferative T Cells in Vivo . Immunology (1994) 83(3):333&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1415051</ArticleId><ArticleId IdType="pubmed">7835956</ArticleId></ArticleIdList></Reference><Reference><Citation>Mourad W, Al-Daccak R, Chatila T, Geha RS. Staphylococcal Superantigens as Inducers of Signal Transduction in MHC Class II-Positive Cells. Semin Immunol (1993) 5(1):47&#x2013;55. doi:&#xa0;10.1006/smim.1993.1007</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/smim.1993.1007</ArticleId><ArticleId IdType="pubmed">8467095</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholl PR, Geha RS. MHC Class II Signaling in B-Cell Activation. Immunol Today (1994) 15(9):418&#x2013;22. doi:&#xa0;10.1016/0167-5699(94)90271-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0167-5699(94)90271-2</ArticleId><ArticleId IdType="pubmed">7524519</ArticleId></ArticleIdList></Reference><Reference><Citation>Florquin S, Amraoui Z, Goldman M. Persistent Production of Th2-Type Cytokines and Polyclonal B Cell Activation After Chronic Administration of Staphylococcal Enterotoxin B in Mice. J Autoimmun (1996) 9(5):609&#x2013;15. doi:&#xa0;10.1006/jaut.1996.0080</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jaut.1996.0080</ArticleId><ArticleId IdType="pubmed">8933276</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhary VR, Tilahun AY, Clark CR, Grande JP, Rajagopalan G. Chronic Exposure to Staphylococcal Superantigen Elicits a Systemic Inflammatory Disease Mimicking Lupus. J Immunol (2012) 189(4):2054&#x2013;62. doi:&#xa0;10.4049/jimmunol.1201097</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1201097</ArticleId><ArticleId IdType="pmc">PMC3462343</ArticleId><ArticleId IdType="pubmed">22798666</ArticleId></ArticleIdList></Reference><Reference><Citation>Khamsi R. Rogue Antibodies Could Be Driving Severe Covid-19. Nature (2021) 590(7844):29&#x2013;31. doi:&#xa0;10.1038/d41586-021-00149-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-00149-1</ArticleId><ArticleId IdType="pubmed">33469204</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, et al. . Autoantibodies Against Type I Ifns in Patients With Life-Threatening Covid-19. Science (2020) 370(6515):eabd4585. doi:&#xa0;10.1126/science.abd4585</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlachoyiannopoulos PG, Magira E, Alexopoulos H, Jahaj E, Theophilopoulou K, Kotanidou A, et al. . Autoantibodies Related to Systemic Autoimmune Rheumatic Diseases in Severely Ill Patients With Covid-19. Ann Rheum Dis (2020) 79(12):1661&#x2013;3. doi:&#xa0;10.1136/annrheumdis-2020-218009</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218009</ArticleId><ArticleId IdType="pubmed">32581086</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Ebinger JE, Mostafa R, Budde P, Gajewski J, Walker B, et al. . Paradoxical Sex-Specific Patterns of Autoantibody Response to Sars-Cov-2 Infection. J Transl Med (2021) 19(1):524. doi:&#xa0;10.1186/s12967-021-03184-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-03184-8</ArticleId><ArticleId IdType="pmc">PMC8716184</ArticleId><ArticleId IdType="pubmed">34965855</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y, Estes SK, Ali RA, Gandhi AA, Yalavarthi S, Shi H, et al. . Prothrombotic Autoantibodies in Serum From Patients Hospitalized With Covid-19. Sci Trans Med (2020) 12(570):eabd3876. doi:&#xa0;10.1126/scitranslmed.abd3876</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abd3876</ArticleId><ArticleId IdType="pmc">PMC7724273</ArticleId><ArticleId IdType="pubmed">33139519</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff MC, Ramonell RP, Saini AS, Haddad NS, Anam FA, Rudolph ME, et al. . Relaxed Peripheral Tolerance Drives Broad De Novo Autoreactivity in Severe Covid-19. Medrxiv (2021) 2020.10.21.20216192. doi:&#xa0;10.1101/2020.10.21.20216192</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.21.20216192</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With Covid-19: A Systematic Review. JAMA Network Open (2021) 4(5):e2111417&#x2013;e. doi:&#xa0;10.1001/jamanetworkopen.2021.11417</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological Sequelae of Long-Haul Covid. Nat Immunol (2022) 23(2):194&#x2013;202. doi:&#xa0;10.1038/s41590-021-01104-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and Burdens of Incident Diabetes in Long Covid: A Cohort Study. Lancet Diabetes Endocrinol (2022) 10(5):311&#x2013;21. doi:&#xa0;10.1016/S2213-8587(22)00044-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber CN, Patel RS, Trachtman R, Lepow L, Amanat F, Krammer F, et al. . Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (Mis-C). Cell (2020) 183(4):982&#x2013;95.e14. doi:&#xa0;10.1016/j.cell.2020.09.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.034</ArticleId><ArticleId IdType="pmc">PMC7489877</ArticleId><ArticleId IdType="pubmed">32991843</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter MJ, Fish M, Jennings A, Doores KJ, Wellman P, Seow J, et al. . Peripheral Immunophenotypes in Children With Multisystem Inflammatory Syndrome Associated With Sars-Cov-2 Infection. Nat Med (2020) 26(11):1701&#x2013;7. doi:&#xa0;10.1038/s41591-020-1054-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1054-6</ArticleId><ArticleId IdType="pubmed">32812012</ArticleId></ArticleIdList></Reference><Reference><Citation>Porritt RA, Binek A, Paschold L, Rivas MN, McArdle A, Yonker LM, et al. . The Autoimmune Signature of Hyperinflammatory Multisystem Inflammatory Syndrome in Children. J Clin Invest (2021) 131(20):e151520. doi:&#xa0;10.1172/jci151520</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci151520</ArticleId><ArticleId IdType="pmc">PMC8516454</ArticleId><ArticleId IdType="pubmed">34437303</ArticleId></ArticleIdList></Reference><Reference><Citation>Consiglio CR, Cotugno N, Sardh F, Pou C, Amodio D, Rodriguez L, et al. . The Immunology of Multisystem Inflammatory Syndrome in Children With Covid-19. Cell (2020) 183(4):968&#x2013;81.e7. doi:&#xa0;10.1016/j.cell.2020.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7474869</ArticleId><ArticleId IdType="pubmed">32966765</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang JJ, Gaines SB, Amezcua ML, Lubell TR, Dayan PS, Dale M, et al. . Upregulation of Type 1 Conventional Dendritic Cells Implicates Antigen Cross-Presentation in Multisystem Inflammatory Syndrome. J Allergy Clin Immunol (2022) 149(3):912&#x2013;22. doi:&#xa0;10.1016/j.jaci.2021.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2021.10.015</ArticleId><ArticleId IdType="pmc">PMC8530782</ArticleId><ArticleId IdType="pubmed">34688775</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardes JP, Mishra N, Tran F, Bahmer T, Best L, Blase JI, et al. . Longitudinal Multi-Omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe Covid-19. Immunity (2020) 53(6):1296&#x2013;314.e9. doi:&#xa0;10.1016/j.immuni.2020.11.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.11.017</ArticleId><ArticleId IdType="pmc">PMC7689306</ArticleId><ArticleId IdType="pubmed">33296687</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsova K, Rubtsov AV, Cancro MP, Marrack P. Age-Associated B Cells: A T-Bet-Dependent Effector With Roles in Protective and Pathogenic Immunity. J Immunol (2015) 195(5):1933&#x2013;7. doi:&#xa0;10.4049/jimmunol.1501209</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1501209</ArticleId><ArticleId IdType="pmc">PMC4548292</ArticleId><ArticleId IdType="pubmed">26297793</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsov AV, Rubtsova K, Fischer A, Meehan RT, Gillis JZ, Kappler JW, et al. . Toll-Like Receptor 7 (Tlr7)-Driven Accumulation of a Novel Cd11c+ B-Cell Population Is Important for the Development of Autoimmunity. Blood (2011) 118(5):1305&#x2013;15. doi:&#xa0;10.1182/blood-2011-01-331462</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-01-331462</ArticleId><ArticleId IdType="pmc">PMC3152497</ArticleId><ArticleId IdType="pubmed">21543762</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsova K, Rubtsov AV, Dyk LFV, Kappler JW, Marrack P. T-Box Transcription Factor T-Bet, a Key Player in a Unique Type of B-Cell Activation Essential for Effective Viral Clearance. Proc Natl Acad Sci (2013) 110(34):E3216&#x2013;E24. doi:&#xa0;10.1073/pnas.1312348110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1312348110</ArticleId><ArticleId IdType="pmc">PMC3752276</ArticleId><ArticleId IdType="pubmed">23922396</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsova K, Rubtsov AV, Thurman JM, Mennona JM, Kappler JW, Marrack P. B Cells Expressing the Transcription Factor T-Bet Drive Lupus-Like Autoimmunity. J Clin Invest (2017) 127(4):1392&#x2013;404. doi:&#xa0;10.1172/JCI91250</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI91250</ArticleId><ArticleId IdType="pmc">PMC5373868</ArticleId><ArticleId IdType="pubmed">28240602</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera-Correa J, Rodriguez A. Divergent Roles of Antiself Antibodies During Infection. Trends Immunol (2018) 39(7):515&#x2013;22. doi:&#xa0;10.1016/j.it.2018.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2018.04.003</ArticleId><ArticleId IdType="pmc">PMC6386177</ArticleId><ArticleId IdType="pubmed">29724608</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeifer J, Thurner B, Kessel C, Fadle N, Kheiroddin P, Regitz E, et al. . Autoantibodies Against Interleukin-1 Receptor Antagonist in Multisystem Inflammatory Syndrome in Children: A Multicentre, Retrospective, Cohort Study. Lancet Rheumatol (2022) 4(5):e329&#x2013;37. doi:&#xa0;10.1016/S2665-9913(22)00064-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(22)00064-9</ArticleId><ArticleId IdType="pmc">PMC8963770</ArticleId><ArticleId IdType="pubmed">35368387</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkon K, Casali P. Nature and Functions of Autoantibodies. Nat Clin Pract Rheumatol (2008) 4(9):491&#x2013;8. doi:&#xa0;10.1038/ncprheum0895</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncprheum0895</ArticleId><ArticleId IdType="pmc">PMC2703183</ArticleId><ArticleId IdType="pubmed">18756274</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker LM, Swank Z, Gilboa T, Senussi Y, Kenyon V, Papadakis L, et al. . Zonulin Antagonist, Larazotide (At1001), as an Adjuvant Treatment for Multisystem Inflammatory Syndrome in Children: A Case Series. Crit Care Explor (2022) 10(2):e0641. doi:&#xa0;10.1097/cce.0000000000000641</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/cce.0000000000000641</ArticleId><ArticleId IdType="pmc">PMC8860335</ArticleId><ArticleId IdType="pubmed">35211683</ArticleId></ArticleIdList></Reference><Reference><Citation>LaRovere KL, Riggs BJ, Poussaint TY, Young CC, Newhams MM, Maamari M, et al. . Neurologic Involvement in Children and Adolescents Hospitalized in the United States for Covid-19 or Multisystem Inflammatory Syndrome. JAMA Neurol (2021) 78(5):536&#x2013;47. doi:&#xa0;10.1001/jamaneurol.2021.0504</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.0504</ArticleId><ArticleId IdType="pmc">PMC7936352</ArticleId><ArticleId IdType="pubmed">33666649</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou SH-Y, Beghi E, Helbok R, Moro E, Sampson J, Altamirano V, et al. . Global Incidence of Neurological Manifestations Among Patients Hospitalized With Covid-19&#x2014;A Report for the Gcs-Neurocovid Consortium and the Energy Consortium. JAMA Network Open (2021) 4(5):e2112131&#x2013;e. doi:&#xa0;10.1001/jamanetworkopen.2021.12131</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.12131</ArticleId><ArticleId IdType="pmc">PMC8114143</ArticleId><ArticleId IdType="pubmed">33974053</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M, Yoo SJ, Clijsters M, Backaert W, Vanstapel A, Speleman K, et al. . Visualizing in Deceased Covid-19 Patients How Sars-Cov-2 Attacks the Respiratory and Olfactory Mucosae But Spares the Olfactory Bulb. Cell (2021) 184(24):5932&#x2013;49.e15. doi:&#xa0;10.1016/j.cell.2021.10.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.10.027</ArticleId><ArticleId IdType="pmc">PMC8564600</ArticleId><ArticleId IdType="pubmed">34798069</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. . Sars-Cov-2 Is Associated With Changes in Brain Structure in Uk Biobank. Nature (2022) 604(7907):697&#x2013;707. doi:&#xa0;10.1038/s41586-022-04569-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Gollub RL. Brain Changes After Covid Revealed by Imaging. Nature (2022) 604(7907):633&#x2013;4. doi:&#xa0;10.1038/d41586-022-00503-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-00503-x</ArticleId><ArticleId IdType="pubmed">35260835</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A, Lu P, Geraghty AC, Song E, Lee MH, Wood J, et al. . Mild Respiratory Sars-Cov-2 Infection Can Cause Multi-Lineage Cellular Dysregulation and Myelin Loss in the Brain. bioRxiv (2022) 2022.01.07.475453. doi:&#xa0;10.1101/2022.01.07.475453</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.07.475453</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, et al. . The Ageing Systemic Milieu Negatively Regulates Neurogenesis and Cognitive Function. Nature (2011) 477(7362):90&#x2013;4. doi:&#xa0;10.1038/nature10357</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10357</ArticleId><ArticleId IdType="pmc">PMC3170097</ArticleId><ArticleId IdType="pubmed">21886162</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola C, Anrather J, Kamel H. Effects of Covid-19 on the Nervous System. Cell (2020) 183(1):16&#x2013;27.e1. doi:&#xa0;10.1016/j.cell.2020.08.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.028</ArticleId><ArticleId IdType="pmc">PMC7437501</ArticleId><ArticleId IdType="pubmed">32882182</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, Bartley CM, Chow RD, Ngo TT, Jiang R, Zamecnik CR, et al. . Divergent and Self-Reactive Immune Responses in the Cns of Covid-19 Patients With Neurological Symptoms. Cell Rep Med (2021) 2(5):100288. doi:&#xa0;10.1016/j.xcrm.2021.100288</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100288</ArticleId><ArticleId IdType="pmc">PMC8091032</ArticleId><ArticleId IdType="pubmed">33969321</ArticleId></ArticleIdList></Reference><Reference><Citation>
Marshall M. Covid and the Brain: Researchers Zero in on How Damage Occurs (2021). Available at: https://www.nature.com/articles/d41586-021-01693-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">34234323</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C, Ferse C, Kreye J, Reincke SM, Sanchez-Sendin E, Rocco A, et al. . High Frequency of Cerebrospinal Fluid Autoantibodies in Covid-19 Patients With Neurological Symptoms. Brain Behav Immun (2021) 93:415&#x2013;9. doi:&#xa0;10.1016/j.bbi.2020.12.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.12.022</ArticleId><ArticleId IdType="pmc">PMC7834471</ArticleId><ArticleId IdType="pubmed">33359380</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreye J, Reincke SM, Pr&#xfc;ss H. Do Cross-Reactive Antibodies Cause Neuropathology in Covid-19? Nat Rev Immunol (2020) 20(11):645&#x2013;6. doi:&#xa0;10.1038/s41577-020-00458-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00458-y</ArticleId><ArticleId IdType="pmc">PMC7537977</ArticleId><ArticleId IdType="pubmed">33024283</ArticleId></ArticleIdList></Reference><Reference><Citation>Batisson M, Strazielle N, Hejmadi M, Thomas D, Ghersi-Egea JF, Etienne J, et al. . Toxic Shock Syndrome Toxin-1 Challenges the Neuroprotective Functions of the Choroidal Epithelium and Induces Neurotoxicity. J Infect Dis (2006) 194(3):341&#x2013;9. doi:&#xa0;10.1086/505428</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/505428</ArticleId><ArticleId IdType="pubmed">16826482</ArticleId></ArticleIdList></Reference><Reference><Citation>Changeux JP, Amoura Z, Rey FA, Miyara M. A Nicotinic Hypothesis for Covid-19 With Preventive and Therapeutic Implications. C R Biol (2020) 343(1):33&#x2013;9. doi:&#xa0;10.5802/crbiol.8</Citation><ArticleIdList><ArticleId IdType="doi">10.5802/crbiol.8</ArticleId><ArticleId IdType="pubmed">32720486</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Luo C, Li W, Xu Z, Zeng C, Bi S, et al. . Structure-Based Preliminary Analysis of Immunity and Virulence of Sars Coronavirus. Viral Immunol (2004) 17(4):528&#x2013;34. doi:&#xa0;10.1089/vim.2004.17.528</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2004.17.528</ArticleId><ArticleId IdType="pubmed">15671749</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateus J, Grifoni A, Tarke A, Sidney J, Ramirez SI, Dan JM, et al. . Selective and Cross-Reactive Sars-Cov-2 T Cell Epitopes in Unexposed Humans. Science (2020) 370(6512):89&#x2013;94. doi:&#xa0;10.1126/science.abd3871</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd3871</ArticleId><ArticleId IdType="pmc">PMC7574914</ArticleId><ArticleId IdType="pubmed">32753554</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzhdygan TP, DeOre BJ, Baldwin-Leclair A, Bullock TA, McGary HM, Khan JA, et al. . The Sars-Cov-2 Spike Protein Alters Barrier Function in 2d Static and 3d Microfluidic in-Vitro Models of the Human Blood-Brain Barrier. Neurobiol Dis (2020) 146:105131. doi:&#xa0;10.1016/j.nbd.2020.105131</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105131</ArticleId><ArticleId IdType="pmc">PMC7547916</ArticleId><ArticleId IdType="pubmed">33053430</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhea EM, Logsdon AF, Hansen KM, Williams LM, Reed MJ, Baumann KK, et al. . The S1 Protein of Sars-Cov-2 Crosses the Blood-Brain Barrier in Mice. Nat Neurosci (2021) 24(3):368&#x2013;78. doi:&#xa0;10.1038/s41593-020-00771-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00771-8</ArticleId><ArticleId IdType="pmc">PMC8793077</ArticleId><ArticleId IdType="pubmed">33328624</ArticleId></ArticleIdList></Reference><Reference><Citation>Bollavaram K, Leeman TH, Lee MW, Kulkarni A, Upshaw SG, Yang J, et al. . Multiple Sites on Sars-Cov-2 Spike Protein Are Susceptible to Proteolysis by Cathepsins B, K, L, S and V. Protein Sci (2021) 30(6):1131&#x2013;43. doi:&#xa0;10.1002/pro.4073</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.4073</ArticleId><ArticleId IdType="pmc">PMC8138523</ArticleId><ArticleId IdType="pubmed">33786919</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, Senussi Y, Alter G, Walt DR. Persistent Circulating Sars-Cov-2 Spike Is Associated with Post-Acute Covid-19 Sequelae. Medrxiv (2022) 2022.06.14.22276401. doi:&#xa0;10.1101/2022.06.14.22276401</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.14.22276401</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>